Greer Murphy M.D., Ph.D.

Publication Details

  • BETA-AMYLOID PRECURSOR DETECTED IN HUMAN CEREBRAL-CORTEX PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY Murphy, G. M., Eng, L. F., Cordell, B., Wang, Y., Ellis, W. G., MEISSNER, L., Tinklenberg, J. R. 1990; 14 (3): 309-317

    Abstract:

    1. Amyloid deposition is one of the pathologic hallmarks of Alzheimer's disease. Since the isolation of the beta-amyloid gene, which revealed that the amyloid forming 4 kD protein is part of a larger precursor, interest has focused on the process by which amyloid is generated and deposited. 2. The authors have developed an immunologic means of detecting amyloid precursor proteins in human brain. 3. The method involves the expression of human beta-amyloid precursor cDNA in a recombinant vaccinia virus, so that antibodies are produced against the precursor proteins in their native forms. 4. By using this expression system, the amyloid precursor immunogens incorporate post-translational modifications that normally occur in vivo; this cannot be achieved with small synthetic peptides. 5. Using antibodies to the 695 residue amyloid precursor, we have detected using Western blot analysis a protein of approximately 120 kD in samples of cerebral cortex from three subjects with Alzheimer's disease and one control subject. 6. Additional antibodies to other amyloid-related proteins have been developed. These are being used to assess the differential expression of the various amyloid precursors and subdomains in additional cases.

    View details for Web of Science ID A1990DC78100004

    View details for PubMedID 2113696

Stanford Medicine Resources:

Footer Links: